Actin binding peptide and purpose thereof
An actin and peptide-binding technology, applied in the field of medicine, can solve the problems of unsuitability for large-scale batch production, unsatisfactory treatment effect, high technical difficulty and high cost, and achieves the promotion of corneal wound healing and transparency recovery, and excellent repair effect. , the effect of synthesis difficulty and cost reduction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0017] Embodiment 1, the preparation of polypeptide LKKTETQ eye drops of the present invention
[0018] Using water as a solvent, sodium chloride and potassium chloride as an osmotic pressure regulator, calcium chloride and magnesium chloride as an electrolyte, and sodium hydroxide as a pH regulator, through a buffer solution containing sodium acetate and sodium citrate, the preparation containing the main drug LKKTETQ eye drops.
[0019] Weigh 6.4g of sodium chloride, 0.75g of potassium chloride, 0.48g of calcium chloride, 0.3g of magnesium chloride, 3.9g of sodium acetate, and 1.7g of sodium citrate into a container, add about 900ml of sterile water for injection, stir to dissolve ; Then add 0.02g actin-binding peptide (LKKTETQ peptide) and mix well, use 0.1mol / L sodium hydroxide solution to adjust the pH to 7.0, and finally add sterile water for injection to 1000ml. The solution was filtered through a sterile membrane, and filled with a sterile polypropylene bottle to obta...
Embodiment 2
[0020] Example 2, LKKTETQ repair test on rat corneal epithelium and matrix refractory damage after lamellar resection
[0021] Clean grade SD rats, 8-9 weeks old, male.
[0022] Rat half-thickness keratectomy model was made: rats were anesthetized by intraperitoneal injection of 1.5% pentobarbital sodium, the right eye was selected as the operated eye, and the corneal epithelium and about 1 / 2 of the depth of the corneal stroma were completely removed with a scalpel.
[0023] Eight lamellar excision model rats were randomly divided into 2 groups, 4 in each group, and LKKTETQ eye drops (specification: 1ml: 0.02mg) and recombinant human epidermal growth factor eye drops (trade name: Yibei, Produced by Guilin Huanuowei Gene Pharmaceutical Co., Ltd., 5ml / bottle), 1 drop / time (equivalent to about 0.03ml), administered 3 times a day at 8:00, 13:00, and 19:00. In the case of corneal perforation in the operated eye during the operation, or corneal ulcer or perforation in the observed ...
Embodiment 3
[0027] Embodiment 3, the research of LKKTETQ to the repairing effect of rabbit eye cornea
[0028] 20 white healthy rabbits, half male and half male, body weight 2±0.1kg / only, were kept in single cages during the experiment.
[0029] A circular wound surface with a diameter of 10mm was artificially created by corneal epidermis scraping and grinding, and the wound surface showed yellow-green fluorescence when examined by sodium fluorescein solution.
[0030] The animals were randomly divided into 5 groups, 4 in each group, half male and half male. The same group of animals was treated with the same concentration of LKKTETQ, and the experimental continuous treatment started 1 h after the wound formation. The right eyes of all animals were used as controls, 2 times a day, 1 drop of normal saline each time; the left eyes were repaired, 2 times a day, 1 drop of LKKTETQ solution each time, until the corneal wound was completely healed.
[0031] The change of corneal trauma area wa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com